RESUMEN
In Parkinson's disease (PD), a compensatory increase in dopamine (DA) turnover occurs in the remaining nigrostriatal dopaminergic neurons, resulting in greater exposure of each neuron to hydrogen peroxide (H2O2) derived from oxidative deamination of DA. The formation of oxyradicals from H2O2 is regarded as a mechanism that could contribute to the progression of PD, and incubation of rat striatal synaptosomes with levodopa (LD) results in an increase in oxidized glutathione (GSSG), indicative of oxidant stress. The present study was undertaken to determine whether striatal GSSG levels increase in response to administration of LD in vivo. Acute and repeated (3-week) treatment of normal rats with LD at doses of up to 100 mg/kg did not increase striatal GSSG despite marked increase in DA turnover. These results suggest that intact striatum may possess increased defense capacity against oxidant stress generated by increased DA turnover as compared with isolated synaptosomes.
Asunto(s)
Antiparkinsonianos/farmacología , Dopamina/metabolismo , Glutatión/metabolismo , Levodopa/farmacología , Estrés Oxidativo/fisiología , Sustancia Negra/metabolismo , Ácido 3,4-Dihidroxifenilacético/metabolismo , Animales , Glutatión/análogos & derivados , Disulfuro de Glutatión , Masculino , Enfermedad de Parkinson/metabolismo , Ratas , Ratas Sprague-Dawley , Sustancia Negra/efectos de los fármacosAsunto(s)
Cuerpo Estriado/metabolismo , Glutatión/análogos & derivados , Levodopa/farmacología , Ácido 3,4-Dihidroxifenilacético/metabolismo , Análisis de Varianza , Animales , Carbidopa/farmacología , Cuerpo Estriado/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Disulfuro de Glutatión , Cinética , Masculino , Ratas , Ratas Sprague-Dawley , Factores de TiempoRESUMEN
Parkinson's disease (PD) is characterized by decreased striatal dopamine, but serotonin (5-HT) is also reduced. Because 5-HT decreases following a single levodopa injection, levodopa has been suggested to contribute to PD's serotonergic deficits. However, in a recent study, rat striatal serotonin levels were reported to increase following 15-day levodopa administration. To address this issue, we administered levodopa (50 mg/kg) to rabbits for 5 days, then measured serotonin, its precursors tryptophan and 5-hydroxytryptophan (5-HTP), and its major metabolite 5-hydroxyindole-acetic acid (5-HIAA) in striatum and CSF. Striatal serotonin and tryptophan were unchanged, while 5-HTP and 5-HIAA increased 4- and 7-fold, respectively. CSF 5-HTP and 5-HIAA were also significantly increased. In levodopa-treated animals, 5-HTP concentrations were moderately correlated (r = 0.679) between striatum and CSF, while weak correlations were present between striatal and CSF concentrations of both serotonin and 5-HIAA. These results suggest that repeated levodopa treatment increases striatal serotonin turnover without changing serotonin content. However, levodopa-induced alterations in striatal serotonin metabolism may not be accurately reflected by measurement of serotonin and 5-HIAA in CSF.